Head_Type,Head_Entity,Relation,Tail_Type,Tail_Entity,Description
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,delusions,阿尔茨海默病患者表现出妄想症状
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,dysfunction in activities of daily living,阿尔茨海默病表现为日常生活功能失调
Treatment,Delta 9-THC,activates,Protein,neprilysin,Delta 9-THC激活Abeta降解酶neprilysin
Treatment,JWH-133,reduces,Pathological_Change,lipid peroxidation,JWH-133减少脂质过氧化
Research_Method,mouse models,demonstrates,Biomarker,Abeta reduction,小鼠模型显示CB2受体激动剂减少Abeta水平
Protein,CB1 receptors,regulates,Clinical_Manifestation,memory function,CB1受体调节记忆功能
Disease,Alzheimer's disease,correlates_with,Biomarker,Aβ42 levels,CB2受体数量增加与Aβ42水平和斑块沉积相关
Protein,CB1 receptors,decreases_in,Brain_Region,frontal cortex,阿尔茨海默病额叶皮层CB1受体数量减少
Treatment,rivastigmine,inhibits,Protein,butyrylcholinesterase,利斯的明抑制丁酰胆碱酯酶
Protein,CB2 receptors,regulates,Clinical_Manifestation,inflammatory pathology,CB2受体调节炎症病理过程
Protein,CB1 receptors,activates,Protein,PPAR-γ,CB1受体激活PPAR-γ受体
Treatment,cannabinoids,reduces,Pathological_Change,neuroinflammation,大麻素减少神经炎症
Disease,Alzheimer's disease,treated_with,Treatment,medical cannabis oil,阿尔茨海默病患者使用医用大麻油进行治疗
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,irritability,阿尔茨海默病患者表现出易怒症状
Treatment,HU-211,inhibits,Protein,NMDA receptors,HU-211抑制NMDA受体
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,aberrant nocturnal motor activity,阿尔茨海默病患者表现出夜间异常运动活动
Treatment,HU-211,protects_against,Pathological_Change,neurotoxicity,HU-211保护细胞免受NMDA诱导的神经毒性
Treatment,cannabinoids,improves,Symptom,behavioural symptoms,大麻素改善阿尔茨海默病患者的行为症状
Protein,CB1 receptors,correlates_with,Clinical_Stage,early stages,阿尔茨海默病早期海马体和额叶CB1受体活性较高
Protein,PPAR-γ,stimulates,Protein,LRP1,PPAR-γ受体刺激LRP1表达
Protein,LRP1,increases,Biomarker,Abeta clearance,LRP1增加Abeta通过血脑屏障的清除
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,sleep disturbances,阿尔茨海默病患者表现出睡眠障碍
Disease,Alzheimer's disease,affects,Brain_Region,hippocampus,阿尔茨海默病早期海马体CB1受体活性较高
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,tau hyperphosphorylation,阿尔茨海默病与tau蛋白过度磷酸化相关
Protein,CB1 receptors,reduces,Protein,GSK3,CB1受体减少GSK3的磷酸化活性形式
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,agitation,阿尔茨海默病患者表现出激越症状
Disease,Alzheimer's disease,affects,Brain_Region,cerebellum,阿尔茨海默病会影响小脑区域
Pathological_Change,oxidative stress,affected_by,Treatment,CB2 receptor agonists,CB2受体激动剂影响氧化应激
Treatment,galantamine,inhibits,Protein,acetylcholinesterase,加兰他敏抑制乙酰胆碱酯酶
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,cognitive impairment,阿尔茨海默病表现为认知功能损害
Protein,CB2 receptors,increases_in,Brain_Region,brain,阿尔茨海默病脑内CB2受体数量增加
Protein,CB2 receptors,promotes,Pathological_Change,autophagy,CB2受体促进自噬
Protein,CB2 receptors,correlates_with,Clinical_Stage,advanced stages,阿尔茨海默病晚期CB2受体表达增加
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,neuritic plaque formation,阿尔茨海默病与神经炎斑块形成相关
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,age,年龄是阿尔茨海默病的风险因素
Protein,GSK3,phosphorylates,Protein,tau,GSK3磷酸化tau蛋白
Protein,CB1 receptors,regulates,Brain_Region,basal ganglia,CB1受体调节基底节功能
Protein,CB1 receptors,regulates,Clinical_Manifestation,cognition,CB1受体调节认知功能
Pathological_Change,Abeta plaque load,affected_by,Treatment,CB1 receptor agonists,CB1受体激动剂影响Abeta斑块负荷
Protein,CB1 receptors,regulates,Brain_Region,hippocampus,CB1受体调节海马体功能
Disease,Alzheimer's disease,affects,Brain_Region,basal ganglia,阿尔茨海默病会影响基底节区域
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,senile plaques,阿尔茨海默病脑内小胶质细胞周围的CB2受体数量增加
Disease,Alzheimer's disease,affects,Brain_Region,frontal cortex,阿尔茨海默病影响额叶皮层的CB1受体数量减少
Treatment,cannabinoids,enhances,Protein,autophagy,大麻素增强自噬
Disease,Alzheimer's disease,treated_with,Treatment,dronabinol,阿尔茨海默病患者使用dronabinol进行治疗
Treatment,cannabinoids,reduces,Biomarker,Abeta levels,大麻素减少Abeta水平和斑块负担
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,behavioural disturbances,阿尔茨海默病表现为行为障碍
Research_Method,cellular and animal models,supports,Role,ECBS in AD,细胞和动物模型支持内源性大麻素系统在阿尔茨海默病中的作用
Disease,Alzheimer's disease,affects,Brain_Region,hippocampus,阿尔茨海默病会影响海马体区域
Protein,amyloid-beta,affected_by,Treatment,cannabinoid compounds,大麻素化合物影响淀粉样蛋白
Clinical_Test,Clinical Global Impression,measures,Clinical_Manifestation,behavioral disturbances,临床总体印象量表用于测量行为障碍
Brain_Region,microglia,affected_by,Treatment,CB2 receptor agonists,CB2受体激动剂影响小胶质细胞
Pathological_Change,neuroinflammation,affected_by,Treatment,CB2 receptor agonists,CB2受体激动剂影响神经炎症
Treatment,memantine,modulates,Protein,NMDA receptor,美金刚调节NMDA受体
Treatment,rivastigmine,inhibits,Protein,acetylcholinesterase,利斯的明抑制乙酰胆碱酯酶
Protein,CB2 receptors,modulates,Pathological_Change,neuroinflammation,CB2受体调节神经炎症
Treatment,donepezil,inhibits,Protein,acetylcholinesterase,多奈哌齐抑制乙酰胆碱酯酶
Treatment,memantine,protects_against,Pathological_Change,excitotoxicity,美金刚通过抑制NMDA受体减少兴奋性毒性
Risk_Factor,CB1 receptor nitrosylation,contributes_to,Disease,Alzheimer's disease,CB1受体硝基化可能是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,treated_with,Treatment,nabilone,阿尔茨海默病患者使用nabilone进行治疗
Clinical_Test,Pittsburgh Agitation Scale,measures,Clinical_Manifestation,agitation,匹兹堡激越量表用于测量激越症状
Protein,tau,affected_by,Treatment,cannabinoid compounds,大麻素化合物影响tau蛋白
Research_Method,in vitro studies,demonstrates,Biomarker,Abeta transit,体外研究显示大麻素促进Abeta通过血脑屏障
Disease,Alzheimer's disease,has_symptom,Clinical_Manifestation,apathy,阿尔茨海默病患者表现出冷漠症状
Disease,Alzheimer's disease,treated_with,Treatment,THC,阿尔茨海默病患者使用THC进行治疗
Treatment,Delta 9-THC,reduces,Biomarker,Abeta plaques,Delta 9-THC减少Abeta斑块
Protein,CB2 receptors,expressed_in,Brain_Region,microglia,CB2受体在微胶质细胞中表达
Clinical_Test,NeuroPsychiatric Inventory,measures,Clinical_Manifestation,behavioral and psychological symptoms,神经精神量表用于测量行为和心理学症状
Treatment,cannabinoids,reduces,Pathological_Change,oxidative stress,大麻素减少氧化应激
Pathological_Change,tau hyperphosphorylation,affected_by,Treatment,CB2 receptor agonists,CB2受体激动剂影响tau蛋白过度磷酸化
Protein,CB2 receptors,expressed_in,Brain_Region,entorhinal cortex,CB2受体在内嗅皮层中表达
Protein,CB1 receptors,regulates,Brain_Region,cerebellum,CB1受体调节小脑功能
Treatment,JWH-133,enhances,Protein,SOD1 and SOD2,JWH-133增强超氧化物歧化酶水平
